Virtu Financial LLC Purchases New Holdings in Tilray Inc (NASDAQ:TLRY)

Virtu Financial LLC bought a new stake in Tilray Inc (NASDAQ:TLRY - Free Report) in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor bought 773,923 shares of the company's stock, valued at approximately $1,029,000. Virtu Financial LLC owned approximately 0.08% of Tilray as of its most recent SEC filing.

Other hedge funds have also made changes to their positions in the company. Bank of Montreal Can increased its position in Tilray by 0.3% in the 3rd quarter. Bank of Montreal Can now owns 2,176,506 shares of the company's stock worth $3,787,000 after purchasing an additional 7,406 shares during the last quarter. Newman Dignan & Sheerar Inc. lifted its stake in Tilray by 61.9% in the fourth quarter. Newman Dignan & Sheerar Inc. now owns 26,150 shares of the company's stock valued at $35,000 after acquiring an additional 10,000 shares during the last quarter. KBC Group NV increased its stake in shares of Tilray by 75.9% during the 4th quarter. KBC Group NV now owns 38,332 shares of the company's stock worth $51,000 after purchasing an additional 16,539 shares during the last quarter. Jones Financial Companies Lllp lifted its stake in shares of Tilray by 125.7% in the 4th quarter. Jones Financial Companies Lllp now owns 31,725 shares of the company's stock valued at $42,000 after purchasing an additional 17,670 shares during the last quarter. Finally, Pallas Capital Advisors LLC lifted its stake in shares of Tilray by 59.4% in the 4th quarter. Pallas Capital Advisors LLC now owns 50,438 shares of the company's stock valued at $67,000 after purchasing an additional 18,792 shares during the last quarter. 9.35% of the stock is owned by hedge funds and other institutional investors.

Remove Ads

Tilray Stock Performance

Tilray stock traded up $0.00 on Tuesday, reaching $0.68. 12,168,685 shares of the stock were exchanged, compared to its average volume of 43,868,957. The company has a current ratio of 2.54, a quick ratio of 1.58 and a debt-to-equity ratio of 0.10. Tilray Inc has a twelve month low of $0.58 and a twelve month high of $2.97. The firm has a fifty day moving average price of $0.90 and a two-hundred day moving average price of $1.29. The stock has a market cap of $641.36 million, a PE ratio of -2.27 and a beta of 2.13.

Tilray (NASDAQ:TLRY - Get Free Report) last released its earnings results on Friday, January 10th. The company reported ($0.10) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of ($0.03) by ($0.07). Tilray had a negative net margin of 30.95% and a negative return on equity of 4.40%. The business had revenue of $210.90 million during the quarter, compared to analyst estimates of $216.34 million. The firm's quarterly revenue was up 8.7% on a year-over-year basis. Sell-side analysts anticipate that Tilray Inc will post -0.2 EPS for the current year.

Analyst Upgrades and Downgrades

Separately, Canaccord Genuity Group boosted their price target on Tilray from $2.00 to $3.00 and gave the stock a "buy" rating in a research report on Monday, January 13th. Three equities research analysts have rated the stock with a hold rating and two have given a buy rating to the company. Based on data from MarketBeat.com, the company presently has an average rating of "Hold" and a consensus price target of $2.70.

Tilray Profile

Tilray, Inc engages in the research, cultivation, processing, and distribution of medical cannabis. The company offers its products in Argentina, Australia, Canada, Chile, Croatia, Cyprus, the Czech Republic, Germany, New Zealand, and South Africa. Tilray, Inc is headquartered in Canada.